Product Name:Cycloastragenol
IUPAC Name:(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-15-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-6,9,14-triol
| Packing Unit | Available Stock | Price($) | Quantity |
|---|---|---|---|
| CM201177-250mg | 1-2 Weeks | ȷDzȌ |
|
|
|||
| Product Overview |
Cycloastragenol (CAG) is a natural triterpenoid derived from the bark of the Astragalus membranaceus plant, which is an important medicinal herb in traditional Chinese medicine. It is known to possess a wide range of biological activities including anti-aging, anti-inflammatory, anti-oxidant, and immunomodulatory effects. CAG is a potent activator of telomerase, an enzyme responsible for the maintenance of telomeres, which are the protective caps at the ends of chromosomes that protect them from damage. Recent studies have suggested that telomere shortening is associated with aging and various age-related diseases, making CAG a potential therapeutic agent for the prevention and treatment of age-related diseases. |
| Synthesis and Application |
Cycloastragenol can be synthesized using a variety of methods, including organic synthesis, chemical synthesis, and biotechnological synthesis. Organic synthesis involves the use of a variety of organic reagents, such as alcohols, acyl halides, and alkyl halides, to produce Cycloastragenol. Chemical synthesis involves the use of various chemical reagents, such as acids, bases, and oxidizing agents, to produce Cycloastragenol. Biotechnological synthesis involves the use of microorganisms, such as bacteria and fungi, to produce Cycloastragenol. |
| Future Directions |
Future studies should focus on further elucidating the pharmacodynamics of Cycloastragenol, as well as exploring its potential therapeutic applications. Additionally, research should be conducted on the potential synergistic effects of Cycloastragenol with other therapeutic agents, as well as its potential for use in combination therapies. Further studies should also be conducted to explore the potential mechanisms of action of Cycloastragenol, as well as its potential side effects and interactions with other drugs. Finally, research should be conducted to explore the potential of Cycloastragenol as an anti-aging agent and to identify biomarkers of Cycloastragenol-induced telomerase activation. |
Search 
+86 21 5895 0110 
